Trial of Lapatinib and Weekly Paclitaxel for Advanced Urothelial Cancer

NCT01700010 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Funding issues.

Conditions

Urothelial Cancer
Bladder Cancer

Interventions

DRUG: Lapatinib and Paclitaxel

Sponsor

University of Michigan Rogel Cancer Center

Collaborators

[object Object]